Wong-Rieger noted the possibilities that have arisen with the advent of new gene therapy forms, including the growing potential to treat diseases that have not yet been considered as candidates for gene therapy.

"The exciting thing for me in this meeting was that there was a recognition that yes, the science is there, and we have to be mindful of the challenges and the opportunities in the science, but also in the whole ecosystem," Wong-Rieger said.

Education and information for patients about the challenges and risks as well as the benefits of these gene therapies will be critical to their success, Wong-Rieger stressed.

Click on the video below to learn more.

Cevec Pharmaceuticals CEO stresses challenges in producing AAV vectors
It will be a real challenge to produce sufficient quantities of gene therapy products, in particular when it comes to adeno-associated virus (AAV) vectors,...

Market access and patient education take center stage at Meeting on the Med
Companies and patient groups tackled reimbursement hurdles and access challenges in a discussion at the Cell & Gene Meeting on the Med last week in Barcelona,...

Investment continues in cell and gene sector, despite disruptions
Investment in the cell and gene therapy sector remains robust, despite the disruptions over the last several years due to the COVID-19 pandemic. That's...

Regional government steps in to boost gene therapy manufacturing in Spain
BARCELONA, SPAIN -- Early cooperation between the government of the Basque region in northern Spain and companies can help boost manufacturing of gene...

Meeting on the Med opens with new data and eyes on the money
BARCELONA, SPAIN -- The Cell & Gene Meeting on the Med conference kicked off on April 20 as speakers assessed the current state of the cell and gene therapy...